Related Experiment Video

Updated: Jun 2, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Novel therapies for non-small cell lung cancer

Jessica S Donington1, Chi Wan Koo, Marc S Ballas

  • 1Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Ave, Suite 9V, New York, NY 10016, USA. Jessica.donington@nyumc.org

Journal of Thoracic Imaging
|April 22, 2011
PubMed

Insights

New lung cancer treatments focus on less invasive options for early stages and targeted therapies for advanced disease. Patient selection is crucial for the effectiveness of these personalized lung cancer treatment approaches.

Area of Science:

  • Oncology
  • Pulmonology
  • Cancer Research

Background:

  • Lung cancer remains the leading cause of cancer-related mortality in the U.S.
  • Current research focuses on improving outcomes for both early and advanced stages of the disease.

Purpose of the Study:

  • To review emerging technologies for lung cancer treatment.
  • To highlight the importance of personalized medicine in oncology.

Main Methods:

  • Review of current literature on lung cancer treatment modalities.
  • Analysis of minimally invasive surgical techniques and ablative therapies.
  • Examination of targeted chemotherapeutic agents for advanced non-small cell lung cancer.

Main Results:

  • Minimally invasive resections and image-guided ablative therapies offer local tumor control for early-stage lung cancer.
  • Targeted therapies, based on molecular understanding, are advancing treatment for advanced non-small cell lung cancer.
  • Treatment efficacy is highly dependent on precise patient selection for specific modalities.

Conclusions:

  • Personalized medicine and patient selection are key to optimizing outcomes in lung cancer care.
  • Advancements in surgical techniques and targeted therapies are transforming lung cancer treatment paradigms.
  • Continued research into lung cancer biology will drive further development of effective, individualized treatments.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...